Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Jan 20;312(7024):169–172. doi: 10.1136/bmj.312.7024.169

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome.

A Gough 1, S Chapman 1, K Wagstaff 1, P Emery 1, E Elias 1
PMCID: PMC2349841  PMID: 8563540

Abstract

Monocycline is the most widely prescribed systemic antibiotic for acne largely because it needs to be given only once or twice a day and seems not to induce resistance. Up to April 1994 11 cases of minocycline induced systemic lupus erythematosus and 16 cases of hepatitis had been reported to the Committee on Safety of Medicines. An analysis of these cases together with seven other cases shows the severity of some of these reactions. Two patients died while taking the drug for acne and a further patient needed a liver transplant. Acne itself can induce arthritis and is often seen in association with autoimmine liver disease, but the clinical and biochemical resolution seen after withdrawal of the drug, despite deterioration of the acne, suggests a drug reaction. In five cases re-exposure led to recurrence. Because reactions may be severe early recognition is important to aid recovery and also to avoid invasive investigations and treatments such as corticosteroids and immunosuppresants. Safer alternatives should be considered for treating acne.

Full text

PDF
170

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boudreaux J. P., Hayes D. H., Mizrahi S., Hussey J., Regenstein F., Balart L. Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity. Transplant Proc. 1993 Apr;25(2):1873–1873. [PubMed] [Google Scholar]
  2. Burette A., Finet C., Prigogine T., De Roy G., Deltenre M. Acute hepatic injury associated with minocycline. Arch Intern Med. 1984 Jul;144(7):1491–1492. [PubMed] [Google Scholar]
  3. Byrne P. A., Williams B. D., Pritchard M. H. Minocycline-related lupus. Br J Rheumatol. 1994 Jul;33(7):674–676. doi: 10.1093/rheumatology/33.7.674. [DOI] [PubMed] [Google Scholar]
  4. Böcker R., Estler C. J., Ludewig-Sandig D. Evaluation of the hepatotoxic potential of minocycline. Antimicrob Agents Chemother. 1991 Jul;35(7):1434–1436. doi: 10.1128/aac.35.7.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DOMZ C. A., McNAMARA D. H., HOLZAPFEL H. F. Tetracycline provocation in lupus erythematosus. Ann Intern Med. 1959 May;50(5):1217–1226. doi: 10.7326/0003-4819-50-5-1217. [DOI] [PubMed] [Google Scholar]
  6. Davies M. G., Kersey P. J. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ. 1989 Jun 3;298(6686):1523–1524. doi: 10.1136/bmj.298.6686.1523-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eady E. A., Jones C. E., Tipper J. L., Cove J. H., Cunliffe W. J., Layton A. M. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ. 1993 Feb 27;306(6877):555–556. doi: 10.1136/bmj.306.6877.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gorard D. A. Late-onset drug fever associated with minocycline. Postgrad Med J. 1990 May;66(775):404–405. doi: 10.1136/pgmj.66.775.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Healy E., Simpson N. Acne vulgaris. BMJ. 1994 Mar 26;308(6932):831–833. doi: 10.1136/bmj.308.6932.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson P. J., McFarlane I. G. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993 Oct;18(4):998–1005. doi: 10.1002/hep.1840180435. [DOI] [PubMed] [Google Scholar]
  11. Knitzer R. H., Needleman B. W. Musculoskeletal syndromes associated with acne. Semin Arthritis Rheum. 1991 Feb;20(4):247–255. doi: 10.1016/0049-0172(91)90020-z. [DOI] [PubMed] [Google Scholar]
  12. Macdonald H., Kelly R. G., Allen E. S., Noble J. F., Kanegis L. A. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther. 1973 Sep-Oct;14(5):852–861. doi: 10.1002/cpt1973145852. [DOI] [PubMed] [Google Scholar]
  13. Matsuura T., Shimizu Y., Fujimoto H., Miyazaki T., Kano S. Minocycline-related lupus. Lancet. 1992 Dec 19;340(8834-8835):1553–1553. doi: 10.1016/0140-6736(92)92810-3. [DOI] [PubMed] [Google Scholar]
  14. Min D. I., Burke P. A., Lewis W. D., Jenkins R. L. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy. 1992;12(1):68–71. [PubMed] [Google Scholar]
  15. Nelis H. J., de Leenheer A. P. Unique metabolic fate of a tetracycline (minocycline) Lancet. 1981 Oct 24;2(8252):938–938. doi: 10.1016/s0140-6736(81)91426-4. [DOI] [PubMed] [Google Scholar]
  16. Otero M., Goodpasture H. C. Pulmonary infiltrates and eosinophilia from minocycline. JAMA. 1983 Nov 18;250(19):2602–2602. [PubMed] [Google Scholar]
  17. Peters R. L., Edmondson H. A., Mikkelsen W. P., Tatter D. Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. Am J Surg. 1967 May;113(5):622–632. doi: 10.1016/0002-9610(67)90308-x. [DOI] [PubMed] [Google Scholar]
  18. Puyana J., Ureña V., Quirce S., Fernandez-Rivas M., Cuevas M., Fraj J. Serum sickness-like syndrome associated with minocycline therapy. Allergy. 1990 May;45(4):313–315. doi: 10.1111/j.1398-9995.1990.tb00502.x. [DOI] [PubMed] [Google Scholar]
  19. RUTENBURG A. M., PINKES S. The hepatotoxicity of intravenous aureomycin. N Engl J Med. 1952 Nov 30;247(21):797–800. doi: 10.1056/NEJM195211202472104. [DOI] [PubMed] [Google Scholar]
  20. Robinson M. J., Rywlin A. M. Tetracycline-associated fatty liver in the male. Report of an autopsied case. Am J Dig Dis. 1970 Sep;15(9):857–862. doi: 10.1007/BF02236049. [DOI] [PubMed] [Google Scholar]
  21. SCHULTZ J. C., ADAMSON J. S., Jr, WORKMAN W. W., NORMAN T. D. FATAL LIVER DISEASE AFTER INTRAVENOUS ADMINISTRATION OF TETRACYCLINE IN HIGH DOSAGE. N Engl J Med. 1963 Nov 7;269:999–1004. doi: 10.1056/NEJM196311072691903. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES